Head and Neck Squamous Cell Carcinoma Market Regional Analysis:
North American Market Insights
The North American head and neck squamous cell carcinoma (HNSCC) market is set to dominate 52% share by 2035. The market growth is due to increasing frequency of head and neck cancer backed by surging ratio of alcohol, and tobacco consumption in people in the region. For instance, around 56,000 cases of oral and pharyngeal cancer are diagnosed in the United States each year, leading to over 12,000 deaths each year.
Moreover, owing to the presence of a strong healthcare network, and the availability of numerous key players in the region, the market for head and neck squamous cell carcinoma (HNSCC) treatment and drugs is anticipated to display significant growth in the North American region. In addition, high awareness among people regarding the disease, along with the presence of favorable reimbursement policies and the availability of quality medical facilities will boost the market revenue.
APAC Market Insights
The Asia Pacific head and neck squamous cell carcinoma (HNSCC) market is predicted to hold share of over 29% during the forecast period. The market growth is impelled by surging population, coupled with significant increase in the geriatric population, the growing prevalence of smoking, and escalating consumption of alcohol among people in the region. For instance, in 2020, the predicted frequency of any tobacco product consumption among men was around 41% in Malaysia, 38% in Thailand, 47% in South Korea, 30% in Singapore, 15% in Australia, and 10% in Hong Kong. In addition, the escalating prescription of immunotherapy drugs for the effective treatment of several kinds of head and neck cancer will fuel the market size.
Europe Market Insights
The market in the European region is set to witness moderate growth till 2035, driven by surging ratio of head and neck cancer among people especially men in the region. Moreover, the escalating consumption of alcohol among youngsters is projected to spike the market revenue. In addition, the usage of tobacco and tobacco products by a large pool of the European population has increased in recent years. For instance, in 2021, almost 188 million people, or 28% of the adult population of Europe, were tobacco users.
